期刊文献+

丙戊酸抗肿瘤作用研究进展 被引量:3

Progress of antitumor effects of vlproic acid
下载PDF
导出
摘要 丙戊酸(VPA)是目前临床上广泛应用的广谱抗癫痫药,近年来发现它同时还是组蛋白去乙酰化酶抑制剂(HDACI)。大量实验研究表明,丙戊酸可以通过诱导细胞周期停滞、凋亡和分化以抑制肿瘤细胞生长增殖,同时还具有抑制肿瘤血管生成和转移作用。丙戊酸的长半衰期和较好的生物利用性以及较低的有效药物浓度,使其作为一种新型抗癌药物有着更好的开发利用前景。
出处 《国外医学(肿瘤学分册)》 2005年第10期766-768,共3页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献20

  • 1Strahl BD, Allis CD. The language of covalent histone modifications.Nature, 2000, 403 (6765): 41-45.
  • 2Marks P, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer,2001,1 (3):194-202.
  • 3Gurvich N, Tsygankova OM, Meinkoth JL, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res, 2004, 64(3) :1079-1086.
  • 4Thelen P, Schweyer S, Hemmerlein B, et al. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. Int J Oncol, 2004, 24 (1) :25-31.
  • 5Gottlicher M, Minucci S, Zhu P,et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.EMBO J, 2001, 20(24): 6969-6978.
  • 6Takai N, Desmond JC, Kumagai T,et al. Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells . Clin Cancer Res, 2004, 10(3) :1141-1149.
  • 7Burgess AJ, Pavey S, Warrener R, et al. Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Mol Pharmacol, 2001, 60(4) :828-837.
  • 8Nakata S, Yoshida T, Horinaka M, et al. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Oncogene ,2004, 23 ( 37 ) :6261-6271.
  • 9Rosato RR, Almenara JA, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1. Cancer Res, 2003, 63 (13):3637-3645.
  • 10Henderson C, Mizzau M, Paroni G,et al. Role of caspases, Bid,and p53 in the apoptotic response triggered by histone deaeetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem, 2003, 278(14) :12579-12589.

同被引文献34

  • 1燕敏,陈尔真,曹伟新,费旭峰,陈雪华.丁酸诱导结肠癌细胞凋亡机制的实验研究[J].肠外与肠内营养,2005,12(5):268-271. 被引量:1
  • 2王生余,张旭辉,于晓妉.新型抗肿瘤药物组蛋白去乙酰化酶抑制剂[J].国际肿瘤学杂志,2006,33(6):404-406. 被引量:12
  • 3时昌文,赵霞,曹莉莉,孙京杰,刘爱武.丙戊酸钠诱导胃癌细胞凋亡及其机制[J].中华胃肠外科杂志,2007,10(5):468-471. 被引量:4
  • 4Sakajiri S, Kumagai T, Kawamata N, et al. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines [ J ]. Exp Hematol,2005,33 : 53- 61
  • 5Hsi LC,Xi X,Lotan R,et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-1ipoxygenase-1 in colorectal cancer cells[ J]. Cancer Res ,2004,64:8778-8781
  • 6Gottlicher M. Valproic acid:an old newly discovered as inhibitor of histone deacetylases [ J ]. Ann Hematol, 2004, 83 :$91-92
  • 7Johnstone RW. Histone-deacetylase inhibitors:novel drugs for the treatment of cancer [ J ]. Nat Rev Drug Discov, 2002,1 : 287-299
  • 8Children's Oncology Group,Fouladi M,Furman WL,et al. Phase Ⅰ study of depsipeptide in pediatric patients with refractory solid tumors:a Children's Oncology Group report [ J ]. J Clin Oncol,2006,24 : 3678-3685
  • 9Zhang Y ,Jung M, Dritschilo A, et al. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors [ J ]. Radiat Res, 2004,161:667-674
  • 10Shabbeer S, Kortenhorst MS, Kachhap S, et al. Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo [ J]. Prostate,2007,67:1099-1110

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部